Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Medicis Pharmaceutical Corporation v. Lupin Ltd. et al
Case Number:
1:09-cv-03062
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 25, 2011
Lupin, Medicis Reach Deal Over Generic Solodyn
Lupin Ltd. said Monday it had reached a deal with Medicis Pharmaceutical Corp. to make a generic version of the acne drug Solodyn and to start a development collaboration worth an initial $20 million, resolving patent litigation in Maryland federal court.
-
February 03, 2010
Medicis Sues Lupin To Halt Generic Acne Drug
Skin health specialist Medicis Pharmaceutical Corp. has hauled Lupin Ltd. into court over the Indian drugmaker's plan to manufacture generic versions of all five approved dosages of acne drug Solodyn.